These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29801587)

  • 1. An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients.
    Alghamdi HI; Alshehri AF; Farhat GN
    J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S1-S6. PubMed ID: 29801587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study.
    Moon SW; Seo JH; Jeon HW; Moon MH
    Thorac Cancer; 2019 May; 10(5):1229-1240. PubMed ID: 30993901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.
    Lüchtenborg M; Riaz SP; Lim E; Page R; Baldwin DR; Jakobsen E; Vedsted P; Lind M; Peake MD; Mellemgaard A; Spicer J; Lang-Lazdunski L; Møller H
    Thorax; 2014 Mar; 69(3):269-73. PubMed ID: 24172710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
    Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
    J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delays during the diagnostic evaluation and treatment of lung cancer.
    Chandra S; Mohan A; Guleria R; Singh V; Yadav P
    Asian Pac J Cancer Prev; 2009; 10(3):453-6. PubMed ID: 19640190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
    Wan J; Wu W
    J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
    Sekine I; Shintani Y; Shukuya T; Takayama K; Inoue A; Okamoto I; Kiura K; Takahashi K; Dosaka-Akita H; Takiguchi Y; Miyaoka E; Okumura M; Yoshino I
    Cancer Sci; 2020 May; 111(5):1685-1691. PubMed ID: 32103551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
    Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
    Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
    van der Leest C; Smit EF; Baas J; Versteijlen RJ; van Walree N; Hoogsteden HC; Aerts JG
    Lung Cancer; 2012 Apr; 76(1):67-71. PubMed ID: 21996089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
    Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
    BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
    Svensson G; Ewers SB; Ohlsson O; Olsson H
    Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
    Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
    Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy.
    Nakazawa K; Kurishima K; Tamura T; Ishikawa H; Satoh H; Hizawa N
    Med Oncol; 2013 Mar; 30(1):367. PubMed ID: 23307241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection.
    Guo Y; Yang L; Liu L; Wei J; Teng F; Zhang J; Zhu Y; Xing P; Li J
    Thorac Cancer; 2020 Oct; 11(10):2782-2792. PubMed ID: 32779385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population based study on the progress in survival of primarily metastatic lung cancer patients in Germany.
    Tzschoppe T; Ohlinger J; Vordermark D; Bedir A; Medenwald D
    Sci Rep; 2024 Jul; 14(1):16005. PubMed ID: 38992115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.